AbstractGet full access to this articleView all access options for this article.Get accessReferences1. Herold KC , Bundy BN , Long SA , Bluestone JA , et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med, 2019; 381: 603–613.
